Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (271-280 of 333) with videos related to

Pageof 34
Sort By:
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.
JAMA Network Open|November 6, 2025
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 DiabetesJeffrey V Lazarus, Leire Agirre-Garrido, Luis Antonio Díaz, et al.
Hepatology (Baltimore, Md.)|January 24, 2021
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus StatementHannes Hagström, Leon A Adams, Alina M Allen, et al.
BMJ Open|May 30, 2025
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre studyVivian D de Jong, Marco Alings, Radan Bruha, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Pageof 34

Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 11, 2025
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-analysisRyan Yanzhe Lim, Faith Xin Ning Tan, Glenn Jun Kit Ho, et al.
Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.
JAMA Network Open|November 6, 2025
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 DiabetesJeffrey V Lazarus, Leire Agirre-Garrido, Luis Antonio Díaz, et al.
Hepatology (Baltimore, Md.)|January 24, 2021
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus StatementHannes Hagström, Leon A Adams, Alina M Allen, et al.
BMJ Open|May 30, 2025
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre studyVivian D de Jong, Marco Alings, Radan Bruha, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
Pageof 34